We recently reported a study1 of the effects of sumatriptan succinate on workplace productivity during a migraine attack, where treatment with subcutaneous sumatriptan reduced migraine-associated productivity loss by approximately 50% compared with placebo. To examine the annual labor costs associated with the differences observed in workplace productivity losses, we have completed a post hoc cost analysis of these data.
Cady RC. Reduction of Labor Costs Associated With Treating Migraine in the Workplace. Arch Intern Med. 1999;159(2):197. doi: